EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Managing Delayed or Missed Doses of Prolonged‐Release Tacrolimus in Transplant Recipients: Implications for Drug Exposure and Recovery Strategies

S Arraki Zava iD, F Maizaud iD, H Sayadi, Y Fromage iD, P Marquet iD, J B Woillard iD, C Monchaud iD

Basic & Clinical Pharmacology & Toxicology · 2026

DOI: 10.1111/bcpt.70157 ↗

At a glance

Journal article in Basic & Clinical Pharmacology & Toxicology, 2026. Written by S Arraki Zava and 6 co-authors. Institution: Pharmacology, Toxicology and Pharmacovigilance Department, Limoges University Hospital, Limoges, France. Major MEDLINE topics: Tacrolimus, Immunosuppressive Agents, Liver Transplantation, Kidney Transplantation. Cited 1 times so far (Crossref); 28 references. The full text is freely available (open access, CC BY 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

In lifelong immunosuppressive therapy, missed doses of prolonged‐release tacrolimus are almost inevitable and may reduce drug exposure, compromising transplant outcomes. Using pharmacokinetic models, we simulated delayed and missed doses in virtual kidney and liver transplant recipients. Our simulations showed that a missed dose significantly lowers exposure, with recovery taking 2–4 days. For delays shorter than 12 h, the full dose should be taken immediately; for delays between 12 and 24 h, half the dose should be administered; for a missed dose, 150% should be given at the next intake. These strategies may help maintain therapeutic exposure and preserve transplant outcomes.

Subjects

MeSH terms (MEDLINE)

TacrolimusImmunosuppressive AgentsLiver TransplantationKidney TransplantationHumansDelayed-Action PreparationsDrug Administration ScheduleComputer SimulationModels, BiologicalGraft RejectionTransplant RecipientsTime Factors

Substances

TacrolimusImmunosuppressive AgentsDelayed-Action Preparations

Authors and institutions

  • Pharmacology, Toxicology and Pharmacovigilance Department, Limoges University Hospital, Limoges, France.
  • Pharmacology and Transplantation, INSERM U1248, University of Limoges, Limoges, France.
  • Hospital-University Federation "Survival Optimization in Organ Transplantation" (FHU SUPORT), Limoges, France.

ORCID profiles: S Arraki Zava, F Maizaud, Y Fromage, P Marquet, J B Woillard, C Monchaud

Cite

APA

Arraki Zava, S., Maizaud, F., Sayadi, H., Fromage, Y., Marquet, P., Woillard, J. B., & Monchaud, C. (2026). Managing Delayed or Missed Doses of Prolonged‐Release Tacrolimus in Transplant Recipients: Implications for Drug Exposure and Recovery Strategies. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70157

Vancouver

Arraki Zava S, Maizaud F, Sayadi H, Fromage Y, Marquet P, Woillard JB, et al. Managing Delayed or Missed Doses of Prolonged‐Release Tacrolimus in Transplant Recipients: Implications for Drug Exposure and Recovery Strategies. Basic & Clinical Pharmacology & Toxicology. 2026. doi:10.1111/bcpt.70157

BibTeX
@article{ArrakiZava2026,
  author = {Arraki Zava, S and Maizaud, F and Sayadi, H and Fromage, Y and Marquet, P and Woillard, J B and Monchaud, C},
  title = {Managing Delayed or Missed Doses of Prolonged‐Release Tacrolimus in Transplant Recipients: Implications for Drug Exposure and Recovery Strategies},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2026},
  doi = {10.1111/bcpt.70157}
}
Start for free →